Journal of Comprehensive Pediatrics

Published by: Kowsar

Use of Brain Natriuretic Peptide in Predicting Severity of Respiratory Distress Syndrome in Neonates

Suresh Kumar 1 , *
Author Information
1 Department of Pediatrics, Chaitanya Hospital, Chandigarh, India
Article information
  • Journal of Comprehensive Pediatrics: May 01, 2014, 5 (2); e16317
  • Published Online: May 20, 2014
  • Article Type: Letter
  • Received: November 21, 2013
  • Revised: December 22, 2013
  • Accepted: February 5, 2014
  • DOI: 10.17795/compreped-16317

To Cite: Kumar S. Use of Brain Natriuretic Peptide in Predicting Severity of Respiratory Distress Syndrome in Neonates, J Compr Ped. 2014 ; 5(2):e16317. doi: 10.17795/compreped-16317.

Copyright © 2014, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA. 2000; 284(7): 843-9[PubMed]
  • 2. Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician. 2007; 76(7): 987-94[PubMed]
  • 3. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012; 3[DOI][PubMed]
  • 4. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics. 2004; 113(6)-3[PubMed]
  • 5. Shahramian I, Noori NM, Sharafi E, Ramezani AA, Hesaraki M. Brain Natriuretic Peptide: A Predictor for Severity Respiratory Distress Syndrome in Newborns. J Compr Ped. 2013; 3(5): 189-93
  • 6. da Graca RL, Hassinger DC, Flynn PA, Sison CP, Nesin M, Auld PA. Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics. 2006; 117(6): 2183-9[DOI][PubMed]
  • 7. Rocha G, Clemente F, Rodrigues T, Guimaraes H. [Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate]. Acta Med Port. 2009; 22(4): 349-54[PubMed]
  • 8. Joseph L, Nir A, Hammerman C, Goldberg S, Ben Shalom E, Picard E. N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants. Am J Perinatol. 2010; 27(5): 381-6[DOI][PubMed]
  • 9. Phua J, Lim TK, Lee KH. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med. 2005; 33(9): 2094-13[PubMed]
  • 10. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail. 2005; 11(5 Suppl)-80[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments